Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02796365 · ClinicalTrials.gov registry record · NA
Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02796365 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 29 participants.
The verdict
NCT02796365, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to identify patients at risk for future heart failure using novel markers of early cardiac damage and determine if exercise training can improve these emerging markers as well as overall fitness and quality of life.
Interventions
- OTHER Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02796365
The ClinicalTrials.gov registry entry for NCT02796365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.
NCT02796365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02796365 about?
NCT02796365 is a clinical study titled "Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy". The purpose of this study is to identify patients at risk for future heart failure using novel markers of early cardiac damage and determine if exercise training can improve these emerging markers as well as overall fitness and quality of life.
What is the current status of trial NCT02796365?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2016-06. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02796365?
The interventions under investigation include: Exercise (OTHER).
Who is sponsoring clinical trial NCT02796365?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.